Non-invasive imaging of mouse hepatitis coronavirus infection reveals determinants of viral replication and spread in vivo

Cellular Microbiology

Volumn 11, Issue 5, 2009, Pages 825-841

  Raaben, Matthijs ^a   Prins, Henk Jan ^b   Martens, Anton C ^b   Rottier, Peter J M ^a   de Haan, Cornelis A M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; LUCIFERASE; VIRUS SPIKE PROTEIN;

ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BRAIN REGION; CERVICAL LYMPH NODE; CONTROLLED STUDY; FOREFOOT; IN VIVO STUDY; INOCULATION; INTESTINE; LIVER; MOUSE; MOUSE STRAIN; MURINE HEPATITIS CORONAVIRUS; NON INVASIVE MEASUREMENT; NONHUMAN; NOSE CAVITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TAIL; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; CORONAVIRUS INFECTIONS; DIAGNOSTIC IMAGING; HEPARITIN SULFATE; INTERFERON TYPE I, RECOMBINANT; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MURINE HEPATITIS VIRUS; VIRUS REPLICATION;

ANIMALIA; CORONAVIRUS; MURINE HEPATITIS VIRUS; MUS;

EID: 64049088249     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2009.01298.x     Document Type: Article

References (71)

1. Bergmann, C.C., Marten, N.W., Hinton, D.R., Parra, B., and Stohlman, S.A. (2001) Cd8 T cell mediated immunity to neurotropic MHV infection. Adv Exp Med Biol 494: 299-308.
2. Blau, D.M., Turbide, C., Tremblay, M., Olson, M., Letourneau, S., Michaliszyn, E. et al. (2001) Targeted disruption of the Ceacam1 (Mhvr) gene leads to reduced susceptibility of mice to mouse hepatitis virus infection. J Virol 75: 8173-8186.
3. Brenner, G.J., Cohen, N., and Moynihan, J.A. (1994) Similar immune response to nonlethal infection with herpes simplex virus-1 in sensitive (Balb/C) and resistant (C57bl/6) strains of mice. Cell Immunol 157: 510-524.
4. Cervantes-Barragan, L., Zust, R., Weber, F., Spiegel, M., Lang, K.S., Akira, S., et al. (2007) Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109: 1131-1137.
5. Compton, S.R., Barthold, S.W., and Smith, A.L. (1993) The cellular and molecular pathogenesis of coronaviruses. Lab Anim Sci 43: 15-28.
6. Contag, C.H., and Bachmann, M.H. (2002) Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4: 235-260.
7. Contag, C.H., Contag, P.R., Mullins, J.I., Spilman, S.D., Stevenson, D.K., and Benaron, D.A. (1995) Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18: 593-603.
8. Contag, C.H., Spilman, S.D., Contag, P.R., Oshiro, M., Eames, B., Dennery, P., et al. (1997) Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66: 523-531.
9. Cook, S.H., and Griffin, D.E. (2003) Luciferase imaging of a neurotropic viral infection in intact animals. J Virol 77: 5333-5338.
10. Durbin, R.K., Mertz, S.E., Koromilas, A.E., and Durbin, J.E. (2002) Pkr protection against intranasal vesicular stomatitis virus infection is mouse strain dependent. Viral Immunol 15: 41-51.
11. Glass, W.G., Chen, B.P., Liu, M.T., and Lane, T.E. (2002) Mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease. Viral Immunol 15: 261-272.
12. de Haan, C.A., Masters, P.S., Shen, X., Weiss, S., and Rottier, P.J. (2002) The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology 296: 177-189.
13. de Haan, C.A., van Genne, L., Stoop, J.N., Volders, H., and Rottier, P.J. (2003) Coronaviruses as vectors: Position dependence of foreign gene expression. J Virol 77: 11312-11323.
14. de Haan, C.A., Stadler, K., Godeke, G.J., Bosch, B.J., and Rottier, P.J. (2004) Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J Virol 78: 6048-6054.
15. de Haan, C.A., Haijema, B.J., Boss, D., Heuts, F.W., and Rottier, P.J. (2005a) Coronaviruses as vectors: Stability of foreign gene expression. J Virol 79: 12742-12751.
16. de Haan, C.A., Li, Z., te Lintelo, E., Bosch, B.J., Haijema, B.J., and Rottier, P.J. (2005b) Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. J Virol 79: 14451-14456.
17. de Haan, C.A., Te Lintelo, E., Li, Z., Raaben, M., Wurdinger, T., Bosch, B.J., and Rottier, P.J. (2006) Cooperative involvement of the S1 and S2 subunits of the murine coronavirus spike protein in receptor binding and extended host range. J Virol 80: 10909-10918.
18. de Haan, C.A., Haijema, B.J., Schellen, P., Schreur, P.W., te Lintelo, E., Vennema, H., and Rottier, P.J. (2008) Cleavage of group 1 coronavirus spike proteins: How furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation. J Virol 82: 6078-6083.
19. Haring, J., and Perlman, S. (2001) Mouse hepatitis virus. Curr Opin Microbiol 4: 462-466.
20. Harmache, A., LeBerre, M., Droineau, S., Giovannini, M., and Bremont, M. (2006) Bioluminescence imaging of live infected salmonids reveals that the fin bases are the major portal of entry for novirhabdovirus. J Virol 80: 3655-3659.
21. Hemmila, E., Turbide, C., Olson, M., Jothy, S., Holmes, K.V., and Beauchemin, N. (2004) Ceacam1a-/-mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59. J Virol 78: 10156-10165.
22. Holmes, K.V., and Lai, M.M.C. (1996) Coronaviruses. In Fields Virology, 3rd edn. Fields, B.N., Knipe, D.M., and Howley, P.M. (eds). Philadelphia, PA: Lippincott-Raven Publishers, pp. 1075-1094.
23. Houtman, J.J., and Fleming, J.O. (1996) Pathogenesis of mouse hepatitis virus-induced demyelination. J Neurovirol 2: 361-376.
24. Hutchens, M., and Luker, G.D. (2007) Applications of bioluminescence imaging to the study of infectious diseases. Cell Microbiol 9: 2315-2322.
25. Iacono, K.T., Kazi, L., and Weiss, S.R. (2006) Both spike and background genes contribute to murine coronavirus neurovirulence. J Virol 80: 6834-6843.
26. Jubelt, B., Ropka, S.L., Goldfarb, S., Waltenbaugh, C., and Oates, R.P. (1991) Susceptibility and resistance to poliovirus-induced paralysis of inbred mouse strains. J Virol 65: 1035-1040.
27. Komurasaki, Y., Nagineni, C.N., Wang, Y., and Hooks, J.J. (1996) Virus Rna persists within the retina in coronavirus-induced retinopathy. Virology 222: 446-450.
28. Kuo, L., Godeke, G.J., Raamsman, M.J., Masters, P.S., and Rottier, P.J. (2000) Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: Crossing the host cell species barrier. J Virol 74: 1393-1406.
29. Lane, T.E., Hardison, J.L., and Walsh, K.B. (2006) Functional diversity of chemokines and chemokine receptors in response to viral infection of the central nervous system. Curr Top Microbiol Immunol 303: 1-27.
30. Lavi, E., Gilden, D.H., Highkin, M.K., and Weiss, S.R. (1984) Persistence of mouse hepatitis virus A59 Rna in a slow virus demyelinating infection in mice as detected by in situ hybridization. J Virol 51: 563-566.
31. Lavi, E., Gilden, D.H., Highkin, M.K., and Weiss, S.R. (1986) The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab Anim Sci 36: 130-135.
32. Lee, E., Hall, R.A., and Lobigs, M. (2004) Common E protein determinants for attenuation of glycosaminoglycan-binding variants of japanese encephalitis and west nile viruses. J Virol 78: 8271-8280.
33. Leipner, C., Grun, K., Schneider, I., Gluck, B., Sigusch, H.H., and Stelzner, A. (2004) Coxsackievirus B3-induced myocarditis: Differences in the immune response of C57bl/6 and Balb/C mice. Med Microbiol Immunol 193: 141-147.
34. Liu, J., and Thorp, S.C. (2002) Cell surface heparan sulfate and its roles in assisting viral infections. Med Res Rev 22: 1-25.
35. Luker, G.D., and Luker, K.E. (2008b) Optical imaging: Current applications and future directions. J Nucleic Med 49: 1-4.
36. Luker, G.D., Bardill, J.P., Prior, J.L., Pica, C.M., Piwnica-Worms, D., and Leib, D.A. (2002) Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol 76: 12149-12161.
37. Luker, K.E., and Luker, G.D. (2008a) Applications of bioluminescence imaging to antiviral research and therapy: Multiple luciferase enzymes and quantitation. Antiviral Res 78: 179-187.
38. Luker, K.E., Hutchens, M., Schultz, T., Pekosz, A., and Luker, G.D. (2005) Bioluminescence imaging of vaccinia virus: Effects of interferon on viral replication and spread. Virology 341: 284-300.
39. McIntosh, K. (1996) Coronaviruses. In Fields Virology, 3rd edn. Fields, B.N., Knipe, D.M., and Howley, P.M. (eds). Philadelphia, PA: Lippincott-Raven Publishers, pp. 401-430.
40. MacNamara, K.C., Chua, M.M., Phillips, J.J., and Weiss, S.R. (2005) Contributions of the viral genetic background and a single amino acid substitution in an immunodominant Cd8+ T-cell epitope to murine coronavirus neurovirulence. J Virol 79: 9108-9118.
41. MacNamara, K.C., Bender, S.J., Chua, M.M., Watson, R., and Weiss, S.R. (2008) Priming of Cd8+ T cells during central nervous system infection with a murine coronavirus is strain dependent. J Virol 82: 6150-6160.
42. Mandl, C.W., Kroschewski, H., Allison, S.L., Kofler, R., Holzmann, H., Meixner, T., and Heinz, F.X. (2001) Adaptation of tick-borne encephalitis virus to Bhk-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J Virol 75: 5627-5637.
43. Marten, N.W., Stohlman, S.A., and Bergmann, C.C. (2001) MHV infection of the CNS: Mechanisms of immune-mediated control. Viral Immunol 14: 1-18.
44. Minagawa, H., Takenaka, A., Mohri, S., and Mori, R. (1987) Protective effect of recombinant murine interferon beta against mouse hepatitis virus infection. Antiviral Res 8: 85-95.
45. Molloy, T., and van't Veer, L.J. (2008) Recent advances in metastasis research. Curr Opin Genet Dev 18: 35-41.
46. Morales, S., Parra, B., Ramakrishna, C., Blau, D.M., and Stohlman, S.A. (2001) B-cell-mediated lysis of cells infected with the neurotropic JHM strain of mouse hepatitis virus. Virology 286: 160-167.
47. Muller, U., Steinhoff, U., Reis, L.F., Hemmi, S., Pavlovic, J., Zinkernagel, R.M., and Aguet, M. (1994) Functional role of type i and type II interferons in antiviral defense. Science 264: 1918-1921.
48. Ohtsuka, N., and Taguchi, F. (1997) Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. J Virol 71: 8860-8863.
49. Olmsted, R.A., Baric, R.S., Sawyer, B.A., and Johnston, R.E. (1984) Sindbis virus mutants selected for rapid growth in cell culture display attenuated virulence in animals. Science 225: 424-427.
50. Parker, J.C., Whiteman, M.D., and Richter, C.B. (1978) Susceptibility of inbred and outbred mouse strains to sendai virus and prevalence of infection in laboratory rodents. Infect Immun 19: 123-130.
51. Perlman, S. (1998) Pathogenesis of coronavirus-induced infections. Review of pathological and immunological aspects. Adv Exp Med Biol 440: 503-513.
52. Perlman, S.R., Lane, T.E., and Buchmeier, M.J. (1999) Coronaviruses: hepatitis, hepatitis, and central nervous system disease. Effects Microbes Immune System 1: 331-348.
53. Phillips, J.J., Chua, M.M., Lavi, E., and Weiss, S.R. (1999) Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: The murine coronavirus spike protein is a major determinant of neurovirulence. J Virol 73: 7752-7760.
54. Robbins, S.G., Detrick, B., and Hooks, J.J. (1990) Retinopathy following intravitreal injection of mice with MHV strain JHM. Adv Exp Med Biol 276: 519-524.
55. Rodriguez, J.F., Rodriguez, D., Rodriguez, J.R., McGowan, E.B., and Esteban, M. (1988) Expression of the firefly luciferase gene in vaccinia virus: A highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc Natl Acad Sci USA 85: 1667-1671.
56. Ross, T.M., Martinez, P.M., Renner, J.C., Thorne, R.G., Hanson, L.R., and Frey, W.H., 2nd (2004) Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: A non-invasive treatment strategy for multiple sclerosis. J Neuroimmunol 151: 66-77.
57. Roth-Cross, J.K., Bender, S.J., and Weiss, S.R. (2008) Murine coronavirus mouse hepatitis virus is recognized by mda5 and induces type I interferon in brain macrophages/microglia. J Virol 82: 9829-9838.
58. Scalzo, A.A., Fitzgerald, N.A., Wallace, C.R., Gibbons, A.E., Smart, Y.C., Burton, R.C., and Shellam, G.R. (1992) The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 149: 581-589.
59. Schickli, J.H., Zelus, B.D., Wentworth, D.E., Sawicki, S.G., and Holmes, K.V. (1997) The murine coronavirus mouse hepatitis virus strain A59 from persistently infected murine cells exhibits an extended host range. J Virol 71: 9499-9507.
60. Schickli, J.H., Thackray, L.B., Sawicki, S.G., and Holmes, K.V. (2004) The N-terminal region of the murine coronavirus spike glycoprotein is associated with the extended host range of viruses from persistently infected murine cells. J Virol 78: 9073-9083.
61. Shah, K., Jacobs, A., Breakefield, X.O., and Weissleder, R. (2004) Molecular imaging of gene therapy for cancer. Gene Ther 11: 1175-1187.
62. Sperry, S.M., Kazi, L., Graham, R.L., Baric, R.S., Weiss, S.R., and Denison, M.R. (2005) Single-amino-acid substitutions in open reading frame (Orf) 1b-Nsp14 and Orf 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice. J Virol 79: 3391-3400.
63. Stiles, L.N., Hardison, J.L., Schaumburg, C.S., Whitman, L.M., and Lane, T.E. (2006) T cell antiviral effector function is not dependent on Cxcl10 following murine coronavirus infection. J Immunol 177: 8372-8380.
64. Thach, D.C., Kimura, T., and Griffin, D.E. (2000) Differences between C57bl/6 and Balb/Cby mice in mortality and virus replication after intranasal infection with neuroadapted sindbis virus. J Virol 74: 6156-6161.
65. Verheije, M.H., Wurdinger, T., van Beusechem, V.W., de Haan, C.A., Gerritsen, W.R., and Rottier, P.J. (2006) Redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapter. J Virol 80: 1250-1260.
66. Verheije, M.H., Raaben, M., Mari, M., Te Lintelo, E.G., Reggiori, F., van Kuppeveld, F.J., et al. (2008) Mouse hepatitis coronavirus rna replication depends on Gbf1-mediated Arf1 activation. PLoS Pathog 4: e1000088.
67. Weinberg, J.B., Lutzke, M.L., Alfinito, R., and Rochford, R. (2004) Mouse strain differences in the chemokine response to acute lung infection with a murine gammaherpesvirus. Viral Immunol 17: 69-77.
68. Weiss, S.R., and Navas-Martin, S. (2005) Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev 69: 635-664.
69. Wu, J.C., Sundaresan, G., Iyer, M., and Gambhir, S.S. (2001) Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol Ther 4: 297-306.
70. Zhou, H., and Perlman, S. (2006) Preferential infection of mature dendritic cells by mouse hepatitis virus strain JHM. J Virol 80: 2506-2514.
71. Zuniga, E.I., Hahm, B., and Oldstone, M.B. (2007) Type I interferon during viral infections: Multiple triggers for a multifunctional mediator. Curr Top Microbiol Immunol 316: 337-357.